7 results on '"Ladeira, Marina S."'
Search Results
2. Protective effect of a spider recombinant toxin in a murine model of Huntington's disease
- Author
-
Joviano-Santos, Julliane V., Valadão, Priscila A.C., Magalhães-Gomes, Matheus P.S., Fernandes, Lorena F., Diniz, Danuza M., Machado, Thatiane C.G., Soares, Kivia B., Ladeira, Marina S., Miranda, Aline S., Massensini, Andre R., Gomez, Marcus V., and Guatimosim, Cristina
- Published
- 2021
- Full Text
- View/download PDF
3. Neuroprotective effect of CTK 01512-2 recombinant toxin at the spinal cord in a model of Huntington's disease.
- Author
-
Joviano-Santos, Julliane V., Valadão, Priscila A. C., Magalhães-Gomes, Matheus P. S., Fernandes, Lorena F., Diniz, Danuza M., Machado, Thatiane C. G., Soares, Kivia B., Ladeira, Marina S., Massensini, Andre R., Gomez, Marcus V., Miranda, Aline S., Tápia, Juan C., and Guatimosim, Cristina
- Subjects
HUNTINGTON disease ,SPIDER venom ,NEUROTOXIC agents ,SPINAL cord ,MOVEMENT disorders ,INTRATHECAL injections ,NERVOUS system ,SPINAL cord injuries ,MUSCULAR atrophy - Abstract
Pha1ß is a neurotoxin from the venom of the Phoneutria nigriventer spider, available as CTK 01512-2, a recombinant peptide. Owing to its antinociceptive and analgesic properties, CTK 01512-2 has been described to alleviate neuroinflammatory responses. Despite the diverse actions of CTK 01512-2 on the nervous system, little is known regarding its neuroprotective effect, especially in neurodegenerative conditions such as Huntington's disease (HD), a genetic movement disorder without cure. Here, we investigated whether CTK 01512-2 has a neuroprotective effect in a mouse model of HD. We hypothesized that spinal cord neurons might represent a therapeutic target, because the spinal cord seems to be involved in the motor symptoms ofHD(BACHD)mice. We treated BACHDmice with CTK 01512-2 by intrathecal injection and performed in vivo motor behavioural and morphological analyses in the CNS (brain and spinal cord) and muscles. Our data showed that intrathecal injection of CTK 01512-2 significantly improved motor performance in the open field task. CTK 01512-2 protected neurons in the spinal cord (but not in the brain) from death, suggesting a local effect. CTK 01512-2 exerted its neuroprotective effect by inhibiting BACHD neuronal apoptosis, as revealed by a reduction in caspase-3 in the spinal cord. CTK 01512-2 was also able to revert BACHD muscle atrophy. In conclusion, our data suggest a novel role for CTK 01512-2 acting directly in the spinal cord to ameliorate morphofunctional aspects of spinal cord neurons and muscles and improve the performance of BACHD mice in motor behavioural tests. Given that HD shares similar symptoms with many neurodegenerative conditions, the findings presented herein might also be applicable to other disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Succinate modulates Ca2+ transient and cardiomyocyte viability through PKA-dependent pathway.
- Author
-
Aguiar, Carla J., Andrade, Vanessa L., Gomes, Enéas R.M., Alves, Márcia N.M., Ladeira, Marina S., Pinheiro, Ana Cristina N., Gomes, Dawidson A., Almeida, Alvair P., Goes, Alfredo M., Resende, Rodrigo R., Guatimosim, Silvia, and Leite, M. Fatima
- Subjects
HEART cells ,G proteins ,SUCCINIC acid ,LABORATORY rats ,GENE expression ,ENZYME inhibitors ,INTRACELLULAR calcium ,CELLULAR signal transduction - Abstract
Abstract: GPR91 is an orphan G-protein-coupled receptor (GPCR) that has been characterized as a receptor for succinate, a citric acid cycle intermediate, in several tissues. In the heart, the role of succinate is unknown. We now report that rat ventricular cardiomyocytes express GPR91. We found that succinate, through GPR91, increases the amplitude and the rate of decline of global Ca
2+ transient, by increasing the phosphorylation levels of ryanodine receptor and phospholamban, two well known Ca2+ handling proteins. The effects of succinate on Ca2+ transient were abolished by pre-treatment with adenylyl cyclase and cAMP-dependent protein kinase (PKA) inhibitors. Direct PKA activation by succinate was further confirmed using a FRET-based A-kinase activity reporter. Additionally, succinate decreases cardiomyocyte viability through a caspase-3 activation pathway, effect also prevented by PKA inhibition. Taken together, these observations show that succinate acts as a signaling molecule in cardiomyocytes, modulating global Ca2+ transient and cell viability through a PKA-dependent pathway. [Copyright &y& Elsevier]- Published
- 2010
- Full Text
- View/download PDF
5. Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signals
- Author
-
Rocha-Resende, Cibele, Roy, Ashbeel, Resende, Rodrigo, Ladeira, Marina S., Lara, Aline, de Morais Gomes, Enéas Ricardo, Prado, Vania F., Gros, Robert, Guatimosim, Cristina, Prado, Marco A.M., and Guatimosim, Silvia
- Subjects
- *
CHOLINERGIC mechanisms , *HEART cells , *CARDIAC hypertrophy , *ACETYLCHOLINE , *SMALL interfering RNA , *CHOLINESTERASE inhibitors , *CELLULAR signal transduction - Abstract
Abstract: Recent work has provided compelling evidence that increased levels of acetylcholine (ACh) can be protective in heart failure, whereas reduced levels of ACh secretion can cause heart malfunction. Previous data show that cardiomyocytes themselves can actively secrete ACh, raising the question of whether this cardiomyocyte derived ACh may contribute to the protective effects of ACh in the heart. To address the functionality of this non-neuronal ACh machinery, we used cholinesterase inhibitors and a siRNA targeted to AChE (acetylcholinesterase) as a way to increase the availability of ACh secreted by cardiac cells. By using nitric oxide (NO) formation as a biological sensor for released ACh, we showed that cholinesterase inhibition increased NO levels in freshly isolated ventricular myocytes and that this effect was prevented by atropine, a muscarinic receptor antagonist, and by inhibition of ACh synthesis or vesicular storage. Functionally, cholinesterase inhibition prevented the hypertrophic effect as well as molecular changes and calcium transient alterations induced by adrenergic overstimulation in cardiomyocytes. Moreover, inhibition of ACh storage or atropine blunted the anti-hypertrophic action of cholinesterase inhibition. Altogether, our results show that cardiomyocytes possess functional cholinergic machinery that offsets deleterious effects of hyperadrenergic stimulation. In addition, we show that adrenergic stimulation upregulates expression levels of cholinergic components. We propose that this cardiomyocyte cholinergic signaling could amplify the protective effects of the parasympathetic nervous system in the heart and may counteract or partially neutralize hypertrophic adrenergic effects. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
6. Graphene-based nanomaterials: biological and medical applications and toxicity.
- Author
-
Tonelli FM, Goulart VA, Gomes KN, Ladeira MS, Santos AK, Lorençon E, Ladeira LO, and Resende RR
- Subjects
- Microscopy, Electron, Transmission, Tissue Engineering, Graphite chemistry, Nanostructures
- Abstract
Graphene and its derivatives, due to a wide range of unique properties that they possess, can be used as starting material for the synthesis of useful nanocomplexes for innovative therapeutic strategies and biodiagnostics. Here, we summarize the latest progress in graphene and its derivatives and their potential applications for drug delivery, gene delivery, biosensor and tissue engineering. A simple comparison with carbon nanotubes uses in biomedicine is also presented. We also discuss their in vitro and in vivo toxicity and biocompatibility in three different life kingdoms (bacterial, mammalian and plant cells). All aspects of how graphene is internalized after in vivo administration or in vitro cell exposure were brought about, and explain how blood-brain barrier can be overlapped by graphene nanomaterials.
- Published
- 2015
- Full Text
- View/download PDF
7. Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway.
- Author
-
Aguiar CJ, Andrade VL, Gomes ER, Alves MN, Ladeira MS, Pinheiro AC, Gomes DA, Almeida AP, Goes AM, Resende RR, Guatimosim S, and Leite MF
- Subjects
- Animals, Calcium-Binding Proteins metabolism, Cells, Cultured, Cyclic AMP-Dependent Protein Kinases metabolism, Male, Microscopy, Confocal, Myocytes, Cardiac drug effects, Myocytes, Cardiac pathology, RNA, Small Interfering genetics, Rats, Rats, Wistar, Receptors, G-Protein-Coupled genetics, Ryanodine Receptor Calcium Release Channel metabolism, Calcium Signaling drug effects, Cell Survival drug effects, Myocytes, Cardiac metabolism, Receptors, G-Protein-Coupled metabolism, Succinic Acid pharmacology
- Abstract
GPR91 is an orphan G-protein-coupled receptor (GPCR) that has been characterized as a receptor for succinate, a citric acid cycle intermediate, in several tissues. In the heart, the role of succinate is unknown. We now report that rat ventricular cardiomyocytes express GPR91. We found that succinate, through GPR91, increases the amplitude and the rate of decline of global Ca(2+) transient, by increasing the phosphorylation levels of ryanodine receptor and phospholamban, two well known Ca(2+) handling proteins. The effects of succinate on Ca(2+) transient were abolished by pre-treatment with adenylyl cyclase and cAMP-dependent protein kinase (PKA) inhibitors. Direct PKA activation by succinate was further confirmed using a FRET-based A-kinase activity reporter. Additionally, succinate decreases cardiomyocyte viability through a caspase-3 activation pathway, effect also prevented by PKA inhibition. Taken together, these observations show that succinate acts as a signaling molecule in cardiomyocytes, modulating global Ca(2+) transient and cell viability through a PKA-dependent pathway., (2009 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.